A team of researchers has found new insight into why some lung cancer patients do not benefit from tumor-infiltrating lymphocyte, or TIL therapy. Their findings may help improve future ways to deliver ...

SOUTH SAN FRANCISCO, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today provided a business update and reported ...

A team of researchers from Moffitt Cancer Center has found new insight into why some lung cancer patients do not benefit from tumor-infiltrating lymphocyte, or TIL therapy. Their findings, published ...

A study of human tumor cells implanted in mice from the MacPherson Lab at Fred Hutch describes a new way to screen for the ...

A next-generation "armored" CAR T cell therapy showed promising results in a small study of patients whose B-cell lymphomas ...

Gene therapies offer incredible promise for treating diseases with a genetic component. Several gene therapies are already ...

Mechanism whereby T cell plasticity, a process originating in the gut and aided by gut microbiota, promotes autoimmunity at gut-distal sites.

Newly discovered oncology drugs called “DNA-encoded tri-specific T-cell engagers,” or “DTriTEs,” engage the immune system ...

After spending years tracing the origin and migration pattern of an unusual type of immune cell in mice, researchers have ...

OSU study links gut bacteria to autoimmune disease progression, focusing on T cell behavior in rheumatoid arthritis.

New research reveals your gut’s friendly bacteria may also be setting off a dangerous chain reaction inside your body.

After spending years tracing the origin and migration pattern of an unusual type of immune cell in mice, researchers have ...